Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial - Neoptolemos, JP; Palmer, DH; Ghaneh, P (Lancet, 2017)
et al.